Promotion of Non-Rapid Eye Movement Sleep and Activation of Reticular Thalamic Neurons by a Novel MT<sub>2</sub>Melatonin Receptor LigandRafael Ochoa‐Sanchez, Gabriella Gobbi, Stefano Comai et al.|Journal of Neuroscience|2011Cited by 120
Selective melatonin MT2 receptor ligands relieve neuropathic pain through modulation of brainstem descending antinociceptive pathwaysMartha López-Canul, Gabriella Gobbi, Annalida Bedini et al.|Pain|2015Cited by 94
<i>N</i>-(Substituted-anilinoethyl)amides: Design, Synthesis, and Pharmacological Characterization of a New Class of Melatonin Receptor LigandsSilvia Rivara, Giorgio Tarzia, Alessio Lodola et al.|Journal of Medicinal Chemistry|2007Cited by 83
Anxiolytic effects of the melatonin MT2 receptor partial agonist UCM765: Comparison with melatonin and diazepamRafael Ochoa‐Sanchez, Gabriella Gobbi, Quentin Rainer et al.|Progress in Neuro-Psychopharmacology and Biological Psychiatry|2012Cited by 66
Melatonin, selective and non-selective MT1/MT2 receptors agonists: Differential effects on the 24-h vigilance statesRafael Ochoa‐Sanchez, Gabriella Gobbi, Stefano Comai et al.|Neuroscience Letters|2014Cited by 35